Advertisement · 728 × 90
#
Hashtag
#sotatercept
Advertisement · 728 × 90
Diventa rimborsabile un nuovo farmaco per l’ipertensione arteriosa polmonare MILANO (ITALPRESS) – L’Agenzia Italiana del Farmaco ha approvato la rimborsabilità di sotatercept, in associazione ad altre terapie, per il trattamento dell’ipertensione arteriosa polmonare. L’annuncio è stato dato a Mi...

TI POTREBBE INTERESSARE: Diventa rimborsabile un nuovo farmaco per l’ipertensione arteriosa polmonare ... LEGGI TUTTO #farmaci #salute #ipertensione #rimborsabilità #sotatercept

0 0 0 0

Zum Thema #iPAH: Meine Werte sind etwas schlechter als mit #Remodulin, aber es war laut Arzt klar, dass #Sotatercept nicht ganz so effektiv wirkt. Da Sotatercept mir insgesamt mehr Lebensqualität bietet (1 Injektion alle 3 Wochen statt dauerhaft Pumpe) und alles in allem gut wirkt, kann ich…

0 0 1 0
Video

Winrevair® de Merck aprobado en China: Nueva era contra la HAP | Sotatercept

📩 info@dengyuemed.com
🔗https://dengyuepharma.com

#HAP #HipertensionArterialPulmonar #Winrevair #Sotatercept #Merck #InnovacionMedica #SaludPulmonar

0 0 0 0
Preview
Marc Humbert : Pulmonary Arterial Hypertension, The Battle of a Committed Doctor · Inserm Inserm Grand Prize winner, lung specialist and researcher Marc Humbert has devoted his career to deciphering the mechanisms of pulmonary arterial hypertension. From disease characterization to the cre...

🎉 Félicitations au Pr Marc Humbert, lauréat du Grand Prix @inserm.fr 2025 !

Ses travaux ont transformé la prise en charge de l’#HTAP et ouvert la voie à de nouvelles thérapies.

👉 À lire : www.inserm.fr/en/news/marc...

#HypertensionPulmonaire #MaladiesRares #Recherche #Sotatercept #Innovation

2 2 0 0
Preview
Acute Hemodynamic Effects of Sotatercept | Circulation

Proud to share our new CIRCULATION paper, released alongside our #AHA2025 presentation: Sotatercept rapidly lowers pulmonary pressures and RV afterload within hours.

🔗 www.ahajournals.org/doi/10.1161/...

#AHA2025 #Circulation #PAH #RVFunction #Sotatercept #PeoplesVentricle

1 2 0 0
Preview
Biologic drug reduces symptoms and hospitalizations in severe pulmonary hypertension – BioNews Central Adding the biologic drug sotatercept to standard therapy within the first year after diagnosis significantly lowers the risk of disease worsening in patients with the most severe form of pulmonary hypertension. ...

Adding the #BiologicDrug #sotatercept to standard therapy within the first year after diagnosis significantly lowers the risk of disease worsening in patients with the most severe form of #PulmonaryHypertension.
#PulmonaryArterialHypertension

1 0 0 0
Post image

🔴 #ERSCongress
Vallerie Victoria McLaughlin, #Michighan, expose les données de l'étude #HYPERION concernant le #sotatercept pour les patients #HTAP nouvellement diagnostiqués.
#PHA #PulmoTension
@phassociation.org
@montanidavid.bsky.social

0 0 1 0
Post image

#PVRI2026 includes sessions on promising novel targets and pathways in #PAH, along with real-world data of #Sotatercept.

🗓️ Get your #abstract in before the closing date of 01 October!

🎟️ Register soon to secure a place in one of the PVRI reserved hotels!

pvrinstitute.org/pvri2026

0 0 0 0
Video

Miss our #PVRIdigital Webinar: #Sotatercept: New Concepts & Clinical Use? PVRI members can watch it on demand: pvrinstitute.org/learning-and... - this webinar is part of the 'Cutting Edge Innovation in Clinical & Experimental PH' sessions.

1 1 0 0
Video

How to define or prove disease modification - catch up on ‪@mark-toshner.bsky.social‬ thought-provoking talk from #DDDS2025 🎥
pvrinstitute.org/learning-hub...
#PAH #BMP #Imatinib #Sotatercept #DiseaseModification

0 0 0 0
Bauch mit Mini-Katheter, von dem ein Schlauch zu einer Pumpe führt.

Bauch mit Mini-Katheter, von dem ein Schlauch zu einer Pumpe führt.

Heute kommt die Pumpe weg. #PAH Ich habe Glück, das #Sotatercept scheint bei mir so gut zu wirken, dass ich nur noch täglich (reichlich) Tabletten sowie alle drei Wochen eine Injektion brauche. #GuteNachrichten #PulmonaleArterielleHypertonie

3 0 1 0
Video

🎥 Missed #DDDS2025 in Amsterdam?
Catch Luke Howard’s talk: How Sotatercept will change the treatment algorithm 💊

▶️ Full recording: pvrinstitute.org/learning-hub...

#PHResearch #DrugDevelopment #Sotatercept #PVRI

1 0 0 0

Apparemment, le #Sotatercept fonctionne bien. À partir de la semaine prochaine, nous réduisons la dose de #Remodulin et, avec beaucoup de chance, je pourrai peut-être vivre sans pompe à partir de début août. C'est un sentiment étrange, un mélange d'espoir, d'excitation et d'insécurité, c'est sûr !

0 0 1 0

So, apparently #Sotatercept works fine in my body. Beginning next week we are reducing #Remodulin and if I am VERY, VERY lucky I may live without a pump from the beginning of August on. It’s a strange feeling, a mixture of hope, excitement and insecurity for sure! #PAH #PulmonaryArterialHypertension

0 0 1 0
Post image

Join our upcoming April Community Call! We’ll be diving into:
- A long-term follow-up study of Sotatercept for PAH
- Lysosomal dysfunction & inflammatory sterol metabolism in PAH

📍 Free to attend – all welcome!
📅 24 April 2025, 16:00 BST
pvrinstitute.org/learning-hub... #PAH #webinar #Sotatercept

0 1 0 0
Post image Post image Post image Post image

#ZENITH Phase 3 RCT: #Sotatercept in High-Risk PAH

✅ Reduced primary endpoint events: 17.4% vs. 54.7% (HR 0.24, P < 0.001)
✅ Lower mortality: 8.1% vs. 15.1%
✅ Fewer PAH 🏥: 9.3% vs. 50.0%
✅ Lower lung transplant rate: 1.2% vs. 7.0%
🩸 Most common AEs: epistaxis, telangiectasia

@nejm.org

1 2 1 0
Video

Missed Ravikumar Sitapara's talk on the combination of seralutinib & sotatercept in preclinical models at #PVRI2025? Now’s your chance to catch up! 🎦 Watch the full talk on demand now pvrinstitute.org/learning-hub... #PAH #seralutinib #sotatercept

2 0 1 0
Preview
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death | NEJM Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The eff...

#ACC
【新規PAH治療薬で高リスク例の増悪有意抑制:RCT/ NEJM】

最大限の従来治療下にて「WHO分類 III度以上」で「1年死亡高リスク」の肺高血圧172例ランダム化、10,6か月 [中央値] 観察:

・ソタテルセプトでプラセボに比べ、「死亡・胚移植・PAH増
悪入院」HRは0.24 [95%CI:0.13-0.43]。NNTは「3」。
・重篤有害事象発生率に有意差なし。

x.gd/CYzgl
#PAH #Sotatercept

1 0 0 0
Preview
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death | NEJM Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The eff...

🚨 ‼️ 🫀🫁 #PHPEEPS
Sharing an important and impactful study published today in @nejm.org : The #ZENITH trial of #sotatercept for high-risk patients with pulmonary arterial hypertension #pah.

Reduction in morbidity/mortality HR, 0.24; 95%CI, 0.13 to 0.43.
www.nejm.org/doi/full/10....

3 1 0 0
Preview
a cartoon character with blue hair and big eyes ALT: a cartoon character with blue hair and big eyes

Anruf gerade vom Krankenhaus: Das #Sotatercept wirkt. Die Zufuhr des Remodulins via Pumpe kann nach und nach heruntergefahren und dann beendet werden. Stattdessen nur noch täglich Tabletten sowie alle drei Wochen Sotatercept-Injektion. Ich könnte heulen❣️ #GuteNachrichten #PAH

0 0 2 0
Post image Post image Post image

✨️ Toutes nos félicitations aux 3 lauréates 🎉 :
🔹️ Athénaïs Boucly, CRMR #PulmoTension @Bicetre pour #HTAP #biomarqueurs #sotatercept
🔹️ Florence JENY, CRMR #OrphaLung @Avicenne pour la #sarcoïdose #facteursenvironnementaux
🔹️ Julie MAZENQ, CRMR #RespiRare @APHM en SHS, ventilation, #SAOS

2 1 1 0
Post image Post image Post image Post image

🔴 en direct #CPLF2025 Retour sur le 7ème congrès de l’#HTP, Le Pr Marc Humbert, @hopitalbicetre.bsky.social, présente les avancées thérapeutiques dans les #HTAP : l’introduction des thérapies émergentes dans l’algorithme thérapeutique notamment le #Sotatercept qui bloque la voie du #TGF-beta

3 2 0 0
Preview
Breakthrough for Pulmonary Hypertension: Sotatercept Gets MHRA Nod In a groundbreaking development, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved Sotatercept, marketed under the name Winrevair, for treating pulmonary arterial hypertensio...

www.linkedin.com/pulse/breakt...

Breakthrough for Pulmonary Hypertension: Sotatercept Gets MHRA Nod

kstrategyand.com/pharma-news

#Winrevair #Sotatercept #PAHTreatment #PulmonaryHypertension #MedicalBreakthrough #MHRAApproval #SelfInjectionTherapy #Humanteconomy #Humantec #KStrategyand

0 0 0 0

2000+ CDNs have Pulmonary Arterial Hypertension. #Sotatercept (Winrevair™) offers hope, but many don’t have access without public funds, #SylviaJones #DougFord prioritize funding for this life-saving drug #PHAwareness #onpoli #TimeMattersPAH @bonnieforontario.bsky.social @maritstilesndp.bsky.social

1 0 0 0
Post image Post image Post image

#HappyHalloween  🎃 👻 Gleich mal die zusätzlichen Spritzen aus dem #Sotatercept Kit zweckentfremdet… 🤪 #PulmonaleHypertonie

1 0 0 0